BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9265968)

  • 1. New perspectives in type 2 Gaucher disease.
    Sidransky E
    Adv Pediatr; 1997; 44():73-107. PubMed ID: 9265968
    [No Abstract]   [Full Text] [Related]  

  • 2. Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene.
    Sidransky E; Sherer DM; Ginns EI
    Pediatr Res; 1992 Oct; 32(4):494-8. PubMed ID: 1437405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
    Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L
    Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 gaucher disease: an expanding phenotype.
    Tayebi N; Stone DL; Sidransky E
    Mol Genet Metab; 1999 Oct; 68(2):209-19. PubMed ID: 10527671
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses.
    Finn LS; Zhang M; Chen SH; Scott CR
    Am J Med Genet; 2000 Mar; 91(3):222-6. PubMed ID: 10756347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital ichthyosis in severe type II Gaucher disease with a homozygous null mutation.
    Haverkaemper S; Marquardt T; Hausser I; Timme K; Kuehn T; Hertzberg C; Rossi R
    Neonatology; 2011; 100(2):194-7. PubMed ID: 21455010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease.
    Sinclair GB; Jevon G; Colobong KE; Randall DR; Choy FY; Clarke LA
    Mol Genet Metab; 2007 Feb; 90(2):148-56. PubMed ID: 17079175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel G377S (c.1246G>T) mutation associated with Gaucher disease type 1.
    Zhou Y; Kraemer RR; Peker D; Wakefield DN; de Idiaquez Bakula DA
    Am J Hematol; 2013 Oct; 88(10):922-3. PubMed ID: 23828321
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?
    Stone DL; van Diggelen OP; de Klerk JB; Gaillard JL; Niermeijer MF; Willemsen R; Tayebi N; Sidransky E
    Eur J Hum Genet; 1999; 7(4):505-9. PubMed ID: 10352942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.
    Mizukami H; Mi Y; Wada R; Kono M; Yamashita T; Liu Y; Werth N; Sandhoff R; Sandhoff K; Proia RL
    J Clin Invest; 2002 May; 109(9):1215-21. PubMed ID: 11994410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S; Lehn P
    J Soc Biol; 2002; 196(2):175-81. PubMed ID: 12360746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme, substrate, and myeloma in Gaucher disease.
    Hughes DA
    Am J Hematol; 2009 Apr; 84(4):199-201. PubMed ID: 19291728
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital ichthyosis preceding neurologic symptoms in two sibs with type 2 Gaucher disease.
    Fujimoto A; Tayebi N; Sidransky E
    Am J Med Genet; 1995 Nov; 59(3):356-8. PubMed ID: 8599361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum.
    Eblan MJ; Goker-Alpan O; Sidransky E
    Fetal Pediatr Pathol; 2005; 24(4-5):205-22. PubMed ID: 16396828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes in Gaucher type I disease: use in enzyme therapy and the creation of an animal model.
    Gregoriadis G; Weereratne H; Blair H; Bull GM
    Prog Clin Biol Res; 1982; 95():681-701. PubMed ID: 6812092
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha.
    Kacher Y; Golan A; Pewzner-Jung Y; Futerman AH
    Blood Cells Mol Dis; 2007; 39(1):124-9. PubMed ID: 17482853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B; Salor O; Yalçin B; Gürakan F; Güçer S; Büyükpamukçu M
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease.
    Farfel-Becker T; Vitner EB; Pressey SN; Eilam R; Cooper JD; Futerman AH
    Hum Mol Genet; 2011 Apr; 20(7):1375-86. PubMed ID: 21252206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gaucher disease].
    Timonen T; Möttönen M; Nousiainen T; Herva R; Savolainen ER
    Duodecim; 2005; 121(19):2068-76. PubMed ID: 16300295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.